Atlantic Trust »

Gt Biopharma shares owned by Atlantic Trust

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by Atlantic Trust from 13F filings

Historical chart of Atlantic Trust investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by Atlantic Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by Atlantic Trust

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.6k 2.0k 0.79

More positions owned by Atlantic Trust

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Astrazeneca Sponsored Adr
Old Dominion Freight Line (ODFL)
Vanguard Index Fds Mid Cap Etf (VO)
Blackstone Group Inc Com Cl A (BX)

View all positions for Atlantic Trust

Top funds holding Gt Biopharma

Scientech Research
SeaCrest Wealth Management
Citadel Advisors
Jane Street
Integrated Wealth Concepts
Geode Capital Management
Coston, McIsaac & Partners
Caitlin John
Wells Fargo & Company
HPM Partners
Am Investment Strategies
Verdence Capital Advisors
Two Sigma Securities
Prospera Financial Services
Hrt Financial

View all funds holding Gt Biopharma